Epigenetic inhibition of the tumor suppressor
ARHI
by light at night‐induced circadian melatonin disruption mediates
STAT
3‐driven paclitaxel resistance in breast cancer
Epigenetic inhibition of the tumor suppressor
ARHI
by light at night‐induced circadian melatonin disruption mediates
STAT
3‐driven paclitaxel resistance in breast cancer
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search